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Seroreactivity to H3N2 swine influenza viruses (SIVs) 
was evaluated in serum samples collected from 843 
people aged 0 to 100 years in 2010 in Luxembourg. 
Sera were analysed by haemagglutination inhibition 
(HI) and virus neutralisation (VN) assays targeting a 
European H3N2 SIV, a North American H3N2 variant 
of swine origin (H3N2v) and human seasonal H3N2 
viruses isolated in 1975, 1995 and 2005. HI antibod-
ies (titre ≥ 10) against European H3N2 SIV were almost 
exclusively detected in those born before 1990, of 
whom 70% were seropositive. HI antibodies against 
H3N2v were predominantly found in those born before 
2000, with 86% seropositive. Titres against the 
North American H3N2v were higher than against the 
European H3N2 SIV. VN patterns were similar, but with 
higher rates and titres. We also demonstrated lower 
seroreactivity to European H3N2 SIV than to North 
American H3N2v virus. Finally, we found a strong cor-
relation between HI titres against the European H3N2 
SIV and H3N2v and their respective human ancestors, 
A/Victoria/3/75 and A/Nanchang/933/95. This finding 
and the minimal contacts between humans and pigs 
in Luxembourg suggest that anti-SIV antibodies in 
human serum samples reflect serological cross-reac-
tivity with historical human H3N2 viruses. Our find-
ings help assess the pandemic risk of H3N2 SIV.
Introduction
Three swine influenza virus (SIV) subtypes, H1N1, H1N2 
and H3N2, are enzootic throughout the world in regions 
with a high density of pigs. The haemagglutinin (HA) 
and neuraminidase (NA) genes of most, if not all, H3N2 
SIVs have been derived from human seasonal influ-
enza A(H3N2) viruses. In Europe, H3N2 SIVs are derived 
from descendants of the A/Hong Kong/1/68 pandemic 
influenza A(H3N2) virus, but they have evolved further 
through genetic reassortment with the endemic avian-
like H1N1 SIVs present in western Europe since the late 
1970s. This has resulted in H3N2 SIVs with human-like 
HA and NA genes and avian-like internal genes [1,2]. In 
North America, H3N2 viruses have become established 
in swine since 1998. They are known as ‘triple-reassor-
tant’ viruses because their HA, NA and polymerase B1 
genes stem from human seasonal H3N2 viruses and 
the remaining internal genes from avian influenza virus 
and classical H1N1 SIV [3]. Since 2009, novel reas-
sortant H3N2 viruses with variable numbers of inter-
nal genes derived from the 2009 pandemic influenza 
A(H1N1)pdm09 virus have been reported frequently 
and this has further complicated the epidemiology 
of swine influenza in the United States (US) [4]. From 
2009 to 2012, these novel influenza A(H1N1)pdm09 
reassortants accounted for 54% of H3N2 SIVs isolated 
[4]. Reassortant viruses with seven genes from the 
triple-reassortant H3N2 SIVs and only the matrix (M) 
gene from the A(H1N1)pdm09 virus have become the 
dominant genotype. These viruses, called H3N2 vari-
ant or H3N2v when isolated from humans, have caused 
many zoonotic infections since 2011 [5].
Antigenic drift in the HA is generally slower in SIVs than 
in human influenza viruses, and pigs can therefore 
serve as reservoirs of older human HAs [6-8]. Swine-
adapted viruses with an HA of human origin could 
initiate a pandemic once immunity within the human 
population has waned sufficiently to allow widespread 
infection, provided that the viruses also have the abil-
ity to spread efficiently from person to person. This 
was observed for the A(H1N1)pdm09 virus that con-
tains the classical swine H1. Evolutionarily, the 1918 
H1N1 pandemic influenza virus was the common ances-
tor of human seasonal and classical swine H1N1 influ-
enza viruses; it has undergone significant antigenic 
drift in humans but remained largely in antigenic stasis 
in swine [9,10]. Consequently, only people born before 
the 1940s had been previously exposed to human sea-
sonal H1N1 viruses with an H1 related to that of A(H1N1)
pdm09, and a pandemic was possible because younger 
people lacked cross-reactive anti-H1 antibodies [11-14]. 
A similar situation could occur with human-adapted 
H3N2 SIVs in the future if they carry the HA of seasonal 
H3N2 viruses that have not circulated in decades.
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Before 2011, only sporadic dead-end zoonotic infec-
tions with H3N2 SIVs had been reported, in humans in 
close contact with pigs. Recently, the H3N2v virus has 
caused 343 human infections in the US from August 
2011 through October 2014 [15]. These infections 
occurred primarily in young children visiting agricul-
tural fairs, and the H3N2v virus did not spread widely 
through the human population [16]. These zoonotic 
infections prompted serological investigations for 
cross-reactive antibodies against H3N2v in people of 
various ages in the US, Canada, Norway and England. 
These studies found that more than half of the adoles-
cents and young adults tested had haemagglutination 
inhibition (HI) antibody titres ≥ 40, which is considered 
as seroprotective [17]. In contrast, younger children 
and older adults typically exhibited lower or negative 
antibody titres [18-22].
Antibodies against the antigenically distinct European 
H3N2 SIV have been reported in ca 50% of humans in 
studies in Italy and Germany between 2008 and 2010 
[23,24]. However, these studies sought to compare 
antibody prevalences in swine workers and non-swine 
workers with a mean age of 45 years, rather than using 
an age-stratified design to assess seropositivity in the 
general population. In this study, we primarily sought 
to compare the seroreactivity to a European H3N2 SIV 
with that to a North American H3N2v virus in people 
in various age groups in Luxembourg who were very 
unlikely to have been exposed to pigs. Importantly, we 
also examined the association between antibody titres 
against swine-origin and those against human sea-
sonal H3N2 influenza viruses.
Methods
Serum samples
A total of 843 anonymised human serum samples 
were randomly selected from the Serum Bank of the 
Laboratoire National de Santé, Luxembourg. The sera 
were collected from patients admitted to hospital for 
various reasons in April or May 2010. The sera were 
from people born between 1910 and 2010 and were 
divided into 10 groups by birth decade. As an example, 
1910s refers to people born between 1910 and 1919. Ca 
10 sera per year of birth and 100 sera per birth dec-
ade were tested. Only the youngest (n = 40 samples) 
and oldest age group (n = 9 samples) had fewer sam-
ples. The sex ratio in each age group was ca 50:50, 
except for the participants born in the 1910s (two male 
vs seven females). No further personal data were col-
lected due to ethical constraints.
H3N2 influenza viruses
We measured serum antibody titres against human 
seasonal H3N2 influenza viruses A/Victoria/3/75, A/
Nanchang/933/95 and A/Wisconsin/67/05. These 
viruses were circulating worldwide during 1976–78, 
1996–98 and 2006–08, respectively, and were rec-
ommended as the influenza vaccine strains by the 
World Health Organization during their time of circu-
lation. We also measured antibody titres against sw/
Gent/172/08, a virus representative of H3N2 SIVs that 
are currently circulating in western Europe, and against 
A/Indiana/08/11, which represents swine-origin H3N2v 
viruses isolated from humans in the US since 2011.
The HA1 amino acid sequences of these five viruses, a 
selection of human seasonal influenza A(H3N2) viruses 
(1968–2012), and European and North American H3N2 
SIVs (1984–2012) were downloaded from GenBank. The 
sequences were compared using the MegAlign pro-
gramme with DNASTAR 5.01 software (DNASTAR, Inc., 
Madison, WI, US). A neighbour-joining phylogenetic 
tree was constructed to compare amino acid sequences 
with MEGA 5.05 software (http://www.megasoft-
ware.net/). The tree was drawn to scale, with branch 
lengths in the same units as those of the evolutionary 
distances used to infer the phylogenetic tree. The evo-
lutionary distances were computed using the Poisson 
correction method and are expressed as the number of 
amino acid substitutions per site.
Antigenic characterisation of the five viruses used 
for serology was performed by HI and virus neutrali-
sation (VN) assays with hyperimmune swine serum 
(for sw/Gent/172/08) or post-infection ferret sera (for 
all other viruses). We used ferret serum against A/
Wuhan/359/95 instead of A/Nanchang/933/95 because 
a ferret serum against the latter virus was not avail-
able. The two viruses have only two amino acid dif-
ferences in the HA1, outside the antigenic region. 
Viruses used in HI assays were propagated in 10 day-
old embryonated chicken eggs (≤ 4 passages); viruses 
used in VN assays underwent an additional passage in 
Madin-Darby canine kidney (MDCK) cells.
Serological assays
All sera were examined in HI assays against the three 
human seasonal H3N2 viruses and the two swine-ori-
gin H3N2 viruses. Since the VN assay is more sensitive 
than the HI assay and highly relevant for protection, 
sera from people born after 1940 were also tested in 
VN assays against the swine-origin viruses. HI and VN 
assays were performed following standard procedures 
[25,26]. Antibody titres were expressed as the recip-
rocal of the highest serum dilution that showed com-
plete inhibition of HA of 4 hemagglutinating units of 
virus (HI assay), or 50% neutralisation of 102 50% tis-
sue culture infectious doses (TCID50) of virus in MDCK 
cells (VN assay). The starting serum dilution was 1:10 
for both assays. Sera with titres ≥ 10 were consid-
ered as seropositive. HI titres ≥ 40 were considered as 
seroprotective.
Statistical analysis
Geometric mean titres (GMTs) of antibody with 95% 
confidence intervals (CI) were calculated for each age 
group against each of the five influenza viruses. A 
numeric value of 5 was assigned to samples with anti-
body titres < 10. Antibody titres between age groups 
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Figure 1
Neighbour-joining phylogenetic tree of HA1 amino acid sequences from human seasonal influenza A(H3N2) viruses and 
European and North American swine influenza A(H3N2) viruses
A/Hong Kong/1/1968
A/England/42/1972
A/Port Chalmers/1/1973
A/Victoria/3/1975
sw/Italy/526/1985
sw/Italy/729/1988
sw/Italy/630/1987
sw/Brabant/1984
sw/Netherlands/L2/1993
sw/Netherlands/784/1991
sw/Finistere/510/1994
sw/Italy/1188/1992
sw/Oedenrode/7c/1996
sw/Breugel/1997
sw/Italy/9181/2000
sw/Gent/220/1992
sw/Belgium/87/1995
sw/Gent/172/2008
sw/Hungary/13509/2007
sw/Gent/492/2011
sw/Flanders/1/1998
sw/Germany/S043/2002
sw/Italy/170/2001
sw/Bakum/IDT1769/2003
sw/Spain/54008/2004
sw/Gent/83/2000
sw/Melle/IDT5706/2006
sw/Gent/131/2005
sw/Gent/538/2010
sw/Gent/130/2012
European swine
A/Texas/1/1977
A/Bangkok/01/1979
A/Philippines/2/1982
A/Christchurch/4/1985
A/Sichuan/02/1987
A/Beijing/353/1989
A/Shandong/9/1993
A/Johannesburg/33/1994
A/Nanchang/933/1995
sw/Illinois/21587/1999
sw/Oklahoma/18717/1999
sw/North Carolina/2003
sw/Colorado/A01203748/2012
sw/Wisconsin/H02AS8/2002
sw/Iowa/H03BF5/2003
sw/Wisconsin/R7c/2001
sw/Oklahoma/008722/2007
sw/Kansas/015252/2009
sw/Minnesota/SG-00234/2005
sw/Ohio/9753/2007
sw/Iowa/01700/2007
sw/Ohio/09SW74E/2009
sw/Missouri/15808/2008
sw/Minnesota/01146/2006
sw/Iowa/63607-13/2008
sw/Indiana/A01076191/2010
sw/Pennsylvania/A01076777/2010
sw/Minnesota/A01327922/2012
sw/Illinois/A01201606/2011
sw/Texas/A01049556/2011
sw/Illinois/A01240774/2012
sw/Indiana/A01202866/2011
A/Indiana/08/2011
sw/New York/A01104005/2011
sw/Indiana/A00968373/2012
North American swine
A/Sydney/5/1997
A/Moscow/10/1999
A/Fujian/411/2002
A/California/7/2004
A/Wisconsin/67/2005
A/Brisbane/10/2007
A/Perth/16/2009
A/Victoria/361/2011
A/Colorado/05/2012
0.02
The viruses used for the present serological studies are indicated in bold.
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were compared using the nonparametric Wilcoxon 
signed-rank test, and differences in the proportion of 
sera with HI titres ≥ 40 were analysed using Fisher’s 
exact test. A p value < 0.05 was considered statisti-
cally significant. Pearson correlation tests were used 
to compare HI antibody titres against human and 
swine-origin viruses. All analyses were performed with 
Graphpad Prism 5.0 (GraphPad Software, Inc., San 
Diego, CA, US).
Results
Relationships between human seasonal and 
swine-origin influenza A(H3N2) viruses
Phylogenetic relationships between the HA1 amino 
acid sequences of human seasonal H3N2 viruses and 
H3N2 SIVs from Europe and North America are shown 
in Figure 1. European and North American H3N2 SIVs 
formed separate clusters, and branched off from 
human viruses at different apparent time points. The 
HA1 of the human A/Victoria/3/75 virus was most 
closely related to the European H3N2 SIVs (87.0% 
identity to sw/Gent/172/08). The HA1 of the human 
A/Nanchang/933/95 virus was most closely related 
to North American H3N2 SIVs (89.7% identity to A/
Indiana/08/11).
Antigenic relationships between human seasonal and 
swine-origin H3N2 viruses are shown in Table 1. All 
viruses reacted with their homologous antisera at HI 
and VN titres ≥ 160. There was minimal cross-reac-
tivity between the H3N2v virus A/Indiana/08/11 and 
the European H3N2 SIV sw/Gent/172/08 using hyper-
immune swine serum against sw/Gent/172/08, and 
ferret serum against A/Indiana/08/11 failed to cross-
react with sw/Gent/172/08. Sw/Gent/172/08 showed 
cross-reaction with antiserum against the human A/
Victoria/3/75 virus in both HI and VN assays (titre = 80). 
A/Indiana/08/11, on the other hand, reacted with 
antiserum against the human A/Wuhan/359/95 virus, 
which is similar to A/Nanchang/933/95, in the VN 
assay (titre = 240), but not in the HI assay. Both swine-
origin viruses had negligible cross-reactivity with A/
Wisconsin/67/05.
Serological status to human seasonal influenza 
A(H3N2) viruses
HI antibody titres ≥ 10 against the A/Victoria/3/75 virus 
were detected in 78% of individuals born before 1990 
(Figure 2). In contrast, only 10% of those born in the 
1990s and none of the children born after 2000 had 
detectable antibodies. HI titres ≥ 40 were most com-
mon in persons born in the 1950s, 1960s and 1970s. 
A larger proportion of people had detectable HI anti-
bodies and titres ≥ 40 against the A/Nanchang/933/95 
virus. Detectable HI antibodies against the latter virus 
were observed in 85% of individuals born before 2000, 
but only in 20% of the children born after 2000. More 
than half of those born in the 1970s, 1980s and 1990s 
had HI titres ≥ 40. Seroprevalence rates against the A/
Wisconsin/67/05 strain had the least variation across 
different age groups. More than half of the people in 
each age category had detectable antibodies, except 
for those born in the 1960s (42%). HI titres ≥ 40 were 
most common in those born after 1990.
GMTs of HI antibodies against the three human seasonal 
H3N2 viruses showed similar age-dependent trends 
as the seroprevalence rates (Table 2). Antibody titres 
against A/Victoria/3/75 were highest in people born 
in the 1950s, 1960s and 1970s. Antibody titres against 
A/Nanchang/933/95 and A/Wisconsin/67/05, on the 
other hand, were highest in people born in the 1980s 
and 1990s and those born in the 1990s, respectively. 
Peak antibody titres against A/Nanchang/933/95 were 
higher than those against either of the other viruses.
Table 1
Cross-reactivity between human seasonal A(H3N2) viruses (A/Victoria/3/75, A/Nanchang/933/95 and A/Wisconsin/67/05) 
and swine-origin A(H3N2) viruses (sw/Gent/172/08 and A/Indiana/08/11) in haemagglutination inhibition and virus 
neutralisation assays, Luxembourg, 2010 (n = 843) 
Virus strain
Antibody titres with serum against
A/Victoria/3/75 A/Wuhan/359/95a A/Wisconsin/67/05 sw/Gent/172/08b A/Indiana/08/11
HI VN HI VN HI VN HI VN HI VN
A/Victoria/3/75 160 960  < 10  < 10  < 10 15 20 120 10  < 10
A/Nanchang/933/95 < 10 20 320 1,280 < 10 15 < 10 10 < 10 80
A/Wisconsin/67/05 < 10 10 < 10 20 160 160 < 10 10 < 10 < 10
sw/Gent/172/08 80 80 < 10 < 10 < 10 15 2,560 5,120 < 10 < 10
A/Indiana/08/11 20 30 < 10 240 < 10 15 10 40 320 2,560
HI: haemagglutination inhibition; VN: virus neutralisation.
a  Ferret serum against A/Wuhan/359/95 was used because ferret serum against A/Nanchang/933/95 was not available. The two viruses are 
antigenically identical.
b  Serum against sw/Gent/172/08 was obtained by hyper-immunisation of swine; the other sera were post-infection ferret sera.
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Serological status to European and North 
American swine-origin influenza A(H3N2) 
viruses
Rates of seroprevalence against the European H3N2 
SIV sw/Gent/172/08 and North American H3N2v 
virus A/Indiana/08/11 were similar to those against 
the human seasonal viruses A/Victoria/3/75 and A/
Nanchang/933/95, respectively (Figure 2). HI antibod-
ies (titres ≥ 10) against sw/Gent/172/08 were almost 
exclusively found in those born before 1990, of whom 
70% were seropositive. HI antibodies against A/
Indiana/08/11 were mainly detected in people born 
before 2000, of whom 86% were seropositive. In con-
trast, fewer than 20% of those born after 1990 had 
antibodies against sw/Gent/172/08, and only 33% of 
children born after 2000 showed antibodies against 
A/Indiana/08/11. Seroprevalences and HI antibody 
GMTs followed similar age-specific patterns for both 
viruses (Figure 2, Table 2). The highest proportions 
of HI titres ≥ 40 and the highest GMTs were observed 
in individuals born in the 1950s to 1970s for sw/
Gent/172/08, and in those born in the 1970s to 1990s 
for A/Indiana/08/11. Nonetheless, the prevalence of 
titres ≥ 40 and the GMTs were higher for A/Indiana/08/11 
than for sw/Gent/172/08 in all age categories (p < 0.05), 
except for those born in 1950s and 1960s (p > 0.05).
Sera from individuals born after 1940 were also exam-
ined for antibodies against the two swine-origin H3N2 
viruses with the VN assay (Table 3). For both viruses, 
VN titres were higher than HI titres (p < 0.05), except 
for antibodies against sw/Gent/172/08 in children born 
after 2000 (p > 0.05). Higher VN antibody titres were 
detected against A/Indiana/08/11 than against sw/
Gent/172/08 (p < 0.05).
Correlations between antibody titres against 
human seasonal and swine-origin influenza 
A(H3N2) viruses
There was a strong correlation between HI antibody 
titres against sw/Gent/172/08 and A/Victoria/3/75 
viruses (r = 0.71), and between those against A/
Indiana/08/11 and A/Nanchang/933/95 viruses 
(r = 0.69) (Table 4). Correlations were low between HI 
Figure 2
Prevalence of haemagglutination inhibition antibodies against three human seasonal influenza A(H3N2) viruses, an 
endemic European H3N2 swine influenza virus and a North American H3N2v virus, by decade of birth, Luxembourg, 2010 
(n = 843)  
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titres against A/Wisconsin/67/05 and sw/Gent/172/08 
(r = 0.25), as well as between those against A/
Wisconsin/67/05 and A/Indiana/08/11 (r = 0.42) (all 
p < 0.01).
Discussion
The present study was designed to investigate the 
extent to which prior exposure, through infection or 
vaccination, to earlier antigenic variants of seasonal 
influenza A(H3N2) viruses was associated with the 
presence of antibodies against swine-origin H3N2 
viruses from Europe and North America in people in 
Luxembourg born between 1910 and 2010. Our results 
demonstrate that as many as 70% of people in the 
study born before 1990 had detectable HI antibod-
ies against the European H3N2 SIV, whereas such 
antibodies were generally lacking in those born after 
1990. The prevalence of antibodies against the anti-
genically distinct H3N2v swine-origin virus was also 
age-dependent: antibodies were predominantly found 
in people born before 2000, of whom 86% were sero-
positive. Our data are consistent with previous studies 
[18-23,27], but we have for the first time demonstrated 
a lower level of seroreactivity to the European H3N2 
SIV than to the H3N2v virus. Although HI titres of ≥ 40 
are generally considered as seroprotective, people 
with lower antibody titres may also have some pro-
tection against H3N2 viruses from swine. Indeed, HI 
assays do not measure mucosal antibodies, antibod-
ies against NA and cell-mediated immunity, which will 
also contribute to protection [28]. The VN assay yielded 
higher seroprevalence rates and antibody titres against 
Table 3
Virus-neutralising antibody titres against swine-origin influenza A(H3N2) viruses sw/Gent/172/08 and A/Indiana/08/11 in 
people born after 1940, Luxembourg, 2010 (n = 643) 
Birth 
decade n
sw/Gent/172/08 A/Indiana/08/11
% sera with titre
GMT (95% CI)
% sera with titre
GMT (95% CI)
≥ 10 ≥ 40 ≥ 10 ≥ 40
1940s 100 77 36 24.0 (18.6–31.0) a 98 71 80.6 (62.6–103.6) a 
1950s 100 94 68 76.4 (56.8–102.7) a 96 69 90.1 (67.3–120.6) a 
1960s 100 93 62 62.6 (46.6–84.0) a 100 82 112.4 (87.7–144.2) a 
1970s 100 99 79 90.4 (70.9–115.1) a 100 94 247.2 (199.7–306.0) a
1980s 104 79 30 22.7 (18.4–28.1) a 100 99 488.1 (410.4–580.5) a 
1990s 99 30 9 8.0 (6.7–9.7) a 97 89 235.4 (172.3–321.7) a 
2000s 40 10 0 5.4 (5.0–5.7) 58 15 13.3 (9.2–19.2) a 
CI: confidence interval; GMT: geometric mean titre.
a GMTs significantly higher (p < 0.05, by Wilcoxon signed-rank test) in the virus neutralisation than in the haemagglutination inhibition assay.
Table 2
Haemagglutination inhibition antibody titres against human and swine-origin influenza A(H3N2) viruses, by age group, 
Luxembourg, 2010 (n = 843) 
Birth decade n A/Victoria/3/75 A/Nanchang/933/95 A/Wisconsin/67/05 sw/Gent/172/08 A/Indiana/08/11
1910s 9 13.6 (6.4–29.1) 20.0 (7.9–50.3) 25.2 (7.0–90.4) 12.6 (4.3–36.6) 29.4 (10.1–85.6)
1920s 91 13.8 (11.5–16.5) 21.4 (17.1–26.8) 18.0 (14.5–22.3) 12.1 (10.2–14.4) 28.2 (21.8–36.5)
1930s 100 12.7 (10.9–14.8) 22.4 (18.3–27.3) 16.1 (13.0–20.0) 11.2 (9.5–13.2) 22.1 (17.4–28.0)
1940s 100 12.4 (10.5–14.7) 14.9 (12.4–17.8) 12.0 (9.7–14.9) 11.1 (9.2–13.4) 17.6 (14.3–21.6)
1950s 100 25.0 (20.2–30.9) 19.2 (15.6–23.5) 12.8 (10.3–16.0) 16.8 (13.7–20.7) 22.0 (17.3–28.1)
1960s 100 30.1 (24.9–36.5) 24.0 (19.2–29.9) 9.7 (7.9–11.8) 24.1 (19.3–30.1) 28.7 (22.8–36.1)
1970s 100 28.7 (23.5–35.0) 29.1 (23.8–35.6) 10.8 (8.9–13.1) 23.1 (19.1–28.0) 69.6 (58.0–83.7)
1980s 104 10.0 (8.7–11.5) 71.0 (59.1–85.3) 18.2 (14.8–22.4) 10.9 (9.4–12.7) 117.8 (97.5–142.2)
1990s 99 5.5 (5.2–5.8) 77.8 (59.5–101.6) 34.3 (26.9–43.7) 6.2 (5.5–7.0) 58.8 (44.6–77.5)
2000s 40 5.0 (5.0–5.0) 6.5 (5.4–7.8) 20.4 (14.6–28.3) 5.2 (4.9–5.4) 7.7 (6.1–9.7)
CI: confidence interval; GMT: geometric mean titre
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both swine-origin influenza viruses than the HI assay. 
This is not surprising, because the VN assay detects a 
broader range of antibodies than the HI assay [29].
We have several reasons to believe that antibodies 
against current swine-origin H3N2 viruses result from 
exposure to historical human H3N2 strains rather than 
from infection with SIVs. Firstly, Luxembourg has a low 
pig density compared with other European regions and 
only 0.07% of the population are employed in the swine 
industry. Furthermore, only 0.99% of the Luxembourg 
swine population tested seropositive against H3N2 SIV 
in 2013 [30]. Secondly, H3N2 SIVs from North America 
have never been detected in swine in Europe. Finally, 
we found a strong correlation between antibody titres 
against swine-origin viruses sw/Gent/172/08 and A/
Indiana/08/11 and their respective human ancestor A/
Victoria/3/75 and A/Nanchang/933/95. Similar corre-
lations have previously been reported between anti-
body titres against the European H3N2 SIV and A/Port 
Chalmers/1/73 [27], and between the H3N2v virus and 
A/Wuhan/359/95 and A/Sydney/5/97 viruses [18,20]. In 
contrast, younger people who had not been exposed to 
these human H3N2 strains in past decades, were gen-
erally seronegative against the swine-origin viruses. In 
addition, our phylogenetic and antigenic analyses, in 
agreement with previous studies [31,32], confirm the 
close relationship between these swine-origin viruses 
and their human H3N2 ancestors.
Despite lower seroreactivity to the European H3N2 SIV 
than to the North American H3N2v virus, only three 
human infections with the European H3N2 SIV have 
been reported between 1993 and 2014 [33,34]. The 
H3N2v viruses, in contrast, have caused 343 human 
infections in the US between 2011 and 2014. It is possi-
ble that the H3N2v virus is more infectious for humans 
than other H3N2 lineages from swine or that more 
people in the US may have opportunities for exposure 
to pigs. The H3N2v is the only North American H3N2 
SIV genotype that has caused widespread infections 
in humans, and although some believe this is due to 
the presence of the pandemic M gene segment, this 
has not been firmly proven [35]. Most H3N2v cases 
reported exposure to pigs at agricultural fairs [16,36]. 
Thousands of fairs are held in summer and autumn 
in North America, and these fairs provide unique set-
tings where pigs from numerous sources can come into 
contact with millions of persons, which may facilitate 
interspecies transmission of influenza viruses. Such 
large-scale pig shows are rare in Europe. Furthermore, 
human cases of animal influenza have been notifiable 
in the US since 2007, which is not the case in Europe, 
and there is much more extensive surveillance for influ-
enza in humans and swine in the US than in Europe.
Our data further support the notion that pigs serve as 
reservoirs for older human H3 HAs against which immu-
nity in the human population will gradually decrease 
over time. Experimental infection studies in pigs and 
in ferrets have shown that prior infection with recent 
seasonal H3N2 viruses offers limited or no protec-
tion against challenge with the European H3N2 SIV or 
H3N2v [31,37]. As such, H3N2 SIVs, and the European 
strains in particular, could potentially contribute to 
pandemic viruses in the future as seroreactivity to the 
respective HAs wanes over time in the human popula-
tion. Yet, it is highly likely that the current substantial 
immunity in people born before 1990 would prevent 
extensive spread of H3N2 SIVs. As for the swine-origin 
A(H1N1)pdm09 virus, pre-pandemic antibodies against 
A(H1N1)pdm09 were present in most individuals born 
before 1944, but were low or absent in younger people 
[11-14]. It may take nearly 50 years before a substan-
tial proportion of the human population would be fully 
susceptible to swine-origin H3N2 viruses. To assure 
the best preparation for swine-origin influenza virus 
pandemics, surveillance of influenza in pigs should 
be expanded and integrated with human public health 
surveillance efforts, and additional studies on the 
cross-reactivity between human and swine influenza 
viruses are warranted.
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